chr13-24892636-T-C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_018451.5(CENPJ):​c.3216+7A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.815 in 1,611,198 control chromosomes in the GnomAD database, including 538,374 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.78 ( 46483 hom., cov: 29)
Exomes 𝑓: 0.82 ( 491891 hom. )

Consequence

CENPJ
NM_018451.5 splice_region, intron

Scores

2
Splicing: ADA: 0.0002216
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: -0.975
Variant links:
Genes affected
CENPJ (HGNC:17272): (centromere protein J) This gene encodes a protein that belongs to the centromere protein family. During cell division, this protein plays a structural role in the maintenance of centrosome integrity and normal spindle morphology, and it is involved in microtubule disassembly at the centrosome. This protein can function as a transcriptional coactivator in the Stat5 signaling pathway, and also as a coactivator of NF-kappaB-mediated transcription, likely via its interaction with the coactivator p300/CREB-binding protein. Mutations in this gene are associated with primary autosomal recessive microcephaly, a disorder characterized by severely reduced brain size and cognitive disability. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Apr 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 13-24892636-T-C is Benign according to our data. Variant chr13-24892636-T-C is described in ClinVar as [Benign]. Clinvar id is 158208.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-24892636-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.831 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CENPJNM_018451.5 linkc.3216+7A>G splice_region_variant, intron_variant Intron 10 of 16 ENST00000381884.9 NP_060921.3 Q9HC77-1A8K8P1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CENPJENST00000381884.9 linkc.3216+7A>G splice_region_variant, intron_variant Intron 10 of 16 1 NM_018451.5 ENSP00000371308.4 Q9HC77-1
CENPJENST00000418179.1 linkc.459+7A>G splice_region_variant, intron_variant Intron 3 of 3 1 ENSP00000399334.1 H0Y5L8
CENPJENST00000616936.4 linkn.3216+7A>G splice_region_variant, intron_variant Intron 10 of 15 1 ENSP00000477511.1 Q9HC77-2
CENPJENST00000545981.6 linkn.3216+7A>G splice_region_variant, intron_variant Intron 10 of 17 2 ENSP00000441090.2 F6VUX8

Frequencies

GnomAD3 genomes
AF:
0.777
AC:
118044
AN:
151832
Hom.:
46453
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.655
Gnomad AMI
AF:
0.791
Gnomad AMR
AF:
0.820
Gnomad ASJ
AF:
0.772
Gnomad EAS
AF:
0.852
Gnomad SAS
AF:
0.666
Gnomad FIN
AF:
0.888
Gnomad MID
AF:
0.722
Gnomad NFE
AF:
0.828
Gnomad OTH
AF:
0.767
GnomAD3 exomes
AF:
0.808
AC:
203202
AN:
251418
Hom.:
82949
AF XY:
0.801
AC XY:
108889
AN XY:
135900
show subpopulations
Gnomad AFR exome
AF:
0.646
Gnomad AMR exome
AF:
0.880
Gnomad ASJ exome
AF:
0.762
Gnomad EAS exome
AF:
0.845
Gnomad SAS exome
AF:
0.672
Gnomad FIN exome
AF:
0.893
Gnomad NFE exome
AF:
0.828
Gnomad OTH exome
AF:
0.814
GnomAD4 exome
AF:
0.819
AC:
1195413
AN:
1459248
Hom.:
491891
Cov.:
36
AF XY:
0.815
AC XY:
591576
AN XY:
726116
show subpopulations
Gnomad4 AFR exome
AF:
0.646
Gnomad4 AMR exome
AF:
0.873
Gnomad4 ASJ exome
AF:
0.761
Gnomad4 EAS exome
AF:
0.864
Gnomad4 SAS exome
AF:
0.677
Gnomad4 FIN exome
AF:
0.893
Gnomad4 NFE exome
AF:
0.831
Gnomad4 OTH exome
AF:
0.798
GnomAD4 genome
AF:
0.777
AC:
118120
AN:
151950
Hom.:
46483
Cov.:
29
AF XY:
0.778
AC XY:
57782
AN XY:
74268
show subpopulations
Gnomad4 AFR
AF:
0.655
Gnomad4 AMR
AF:
0.820
Gnomad4 ASJ
AF:
0.772
Gnomad4 EAS
AF:
0.852
Gnomad4 SAS
AF:
0.665
Gnomad4 FIN
AF:
0.888
Gnomad4 NFE
AF:
0.828
Gnomad4 OTH
AF:
0.759
Alfa
AF:
0.808
Hom.:
31121
Bravo
AF:
0.770
Asia WGS
AF:
0.725
AC:
2520
AN:
3478
EpiCase
AF:
0.813
EpiControl
AF:
0.815

ClinVar

Significance: Benign
Submissions summary: Benign:14
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Apr 09, 2014
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:4
Mar 03, 2015
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Apr 20, 2017
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Seckel syndrome 4 Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 22, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Microcephaly 6, primary, autosomal recessive Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 22, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.088
DANN
Benign
0.32
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00022
dbscSNV1_RF
Benign
0.0040
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs9318917; hg19: chr13-25466774; API